CA Stock MarketDetailed Quotes

TTI Thiogenesis Therapeutics Corp

Watchlist
  • 0.760
  • 0.0000.00%
15min DelayTrading Aug 27 16:00 ET
34.58MMarket Cap-6909P/E (TTM)

Thiogenesis Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-16.67%731.71K
-22.91%853.32K
163.62%5.21M
291.84%2.13M
55.16%1.1M
76.63%878.08K
382.79%1.11M
54.40%1.97M
43.08%542.49K
68.47%705.94K
Selling and administrative expenses
30.52%263.16K
22.27%281.89K
11.79%1.04M
-26.05%338.27K
27.31%230.95K
-11.01%201.62K
317.85%230.55K
204.28%933.09K
508.61%457.45K
2.96%181.41K
-General and administrative expense
30.52%263.16K
22.27%281.89K
11.79%1.04M
-26.05%338.27K
27.31%230.95K
-11.01%201.62K
317.85%230.55K
204.28%933.09K
508.61%457.45K
2.96%181.41K
Research and development costs
-30.73%468.56K
-34.80%571.43K
286.93%4.16M
1,399.84%1.79M
64.79%864.36K
150.02%676.46K
403.37%876.4K
-21.23%1.08M
-74.43%119.17K
116.00%524.53K
Other operating expenses
----
----
----
----
----
----
----
91.32%-34.13K
----
----
Operating profit
16.67%-731.71K
22.91%-853.32K
-163.62%-5.21M
-291.84%-2.13M
-55.16%-1.1M
-76.63%-878.08K
-382.79%-1.11M
-54.40%-1.97M
-43.08%-542.49K
-68.47%-705.94K
Net non-operating interest income (expenses)
14.90%57.68K
48.13%59.64K
8,217.06%171.17K
565.63%35.78K
28,879.35%44.92K
50.2K
1,259.56%40.26K
168.53%2.06K
9.14%5.38K
105.20%155
Non-operating interest income
14.90%57.68K
48.13%59.64K
2,669.21%171.17K
478.94%35.78K
28,879.35%44.92K
--50.2K
--40.26K
--6.18K
--6.18K
--155
Non-operating interest expense
----
----
--0
--0
--0
----
----
37.30%4.12K
120.84%805
----
Other net income (expenses)
153.41%22.71K
83.12K
98.56%-28.16K
-79.82%18.52K
-4.16K
-42.52K
-3,158.38%-1.95M
149.96%91.77K
Gain on sale of security
153.41%22.71K
--83.12K
-145.81%-28.16K
-85.86%18.52K
---4.16K
---42.52K
----
-3.67%61.47K
256.67%130.95K
----
Special income (charges)
----
----
--0
----
----
----
----
---5.27K
----
----
-Less:Other special charges
----
----
----
----
----
----
----
--5.27K
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
----
---2.01M
---33.9K
----
Income before tax
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
-86.42%-705.78K
Income tax
Earnings from equity interest net of tax
Net income
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
-86.42%-705.78K
Net income continuous operations
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
-86.42%-705.78K
Noncontrolling interests
Net income attributable to the company
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
-86.42%-705.78K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
-86.42%-705.78K
Diluted earnings per share
50.00%-0.01
33.33%-0.02
18.75%-0.13
-400.00%-0.05
-50.00%-0.03
89.47%-0.02
63.21%-0.03
-266.56%-0.16
17.30%-0.01
36.61%-0.02
Basic earnings per share
50.00%-0.01
33.33%-0.02
18.75%-0.13
-400.00%-0.05
-50.00%-0.03
89.47%-0.02
63.21%-0.03
-266.56%-0.16
17.30%-0.01
36.61%-0.02
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -16.67%731.71K-22.91%853.32K163.62%5.21M291.84%2.13M55.16%1.1M76.63%878.08K382.79%1.11M54.40%1.97M43.08%542.49K68.47%705.94K
Selling and administrative expenses 30.52%263.16K22.27%281.89K11.79%1.04M-26.05%338.27K27.31%230.95K-11.01%201.62K317.85%230.55K204.28%933.09K508.61%457.45K2.96%181.41K
-General and administrative expense 30.52%263.16K22.27%281.89K11.79%1.04M-26.05%338.27K27.31%230.95K-11.01%201.62K317.85%230.55K204.28%933.09K508.61%457.45K2.96%181.41K
Research and development costs -30.73%468.56K-34.80%571.43K286.93%4.16M1,399.84%1.79M64.79%864.36K150.02%676.46K403.37%876.4K-21.23%1.08M-74.43%119.17K116.00%524.53K
Other operating expenses ----------------------------91.32%-34.13K--------
Operating profit 16.67%-731.71K22.91%-853.32K-163.62%-5.21M-291.84%-2.13M-55.16%-1.1M-76.63%-878.08K-382.79%-1.11M-54.40%-1.97M-43.08%-542.49K-68.47%-705.94K
Net non-operating interest income (expenses) 14.90%57.68K48.13%59.64K8,217.06%171.17K565.63%35.78K28,879.35%44.92K50.2K1,259.56%40.26K168.53%2.06K9.14%5.38K105.20%155
Non-operating interest income 14.90%57.68K48.13%59.64K2,669.21%171.17K478.94%35.78K28,879.35%44.92K--50.2K--40.26K--6.18K--6.18K--155
Non-operating interest expense ----------0--0--0--------37.30%4.12K120.84%805----
Other net income (expenses) 153.41%22.71K83.12K98.56%-28.16K-79.82%18.52K-4.16K-42.52K-3,158.38%-1.95M149.96%91.77K
Gain on sale of security 153.41%22.71K--83.12K-145.81%-28.16K-85.86%18.52K---4.16K---42.52K-----3.67%61.47K256.67%130.95K----
Special income (charges) ----------0-------------------5.27K--------
-Less:Other special charges ------------------------------5.27K--------
Other non-operating income (expenses) -------------------------------2.01M---33.9K----
Income before tax 25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K-86.42%-705.78K
Income tax
Earnings from equity interest net of tax
Net income 25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K-86.42%-705.78K
Net income continuous operations 25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K-86.42%-705.78K
Noncontrolling interests
Net income attributable to the company 25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K-86.42%-705.78K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K-86.42%-705.78K
Diluted earnings per share 50.00%-0.0133.33%-0.0218.75%-0.13-400.00%-0.05-50.00%-0.0389.47%-0.0263.21%-0.03-266.56%-0.1617.30%-0.0136.61%-0.02
Basic earnings per share 50.00%-0.0133.33%-0.0218.75%-0.13-400.00%-0.05-50.00%-0.0389.47%-0.0263.21%-0.03-266.56%-0.1617.30%-0.0136.61%-0.02
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg